富一国际控股(01470.HK)向山东润银购买尿素及复合肥并转售
格隆汇7月23日丨富一国际控股(01470.HK)公告,集团于日常贸易业务过程中担任代理,安排供应商向客户供应若干原材料及产品。集团根据客户指定的产品价格、数量及品质及交付时间表挑选供应商。根据贸易安排,集团首先向供应商购买原材料或产品,然后转售予客户。
截至2018年及2019年4月30日止两个年度,集团向山东润银购买尿素及复合肥等肥料并转售予独立客户。截至2018年及2019年4月30日止两个年度各年,购买事项的交易额分别约为4900万港元及1.869亿港元。
截至2019年4月30日止年度,集团向独立供应商购买粗甘油并转售予山东福富,销售事项交易额约为700万港元。截至2019年4月30日止年度,集团向山东农源购买肥料并向独立客户销售,以及向山东农源销售从独立第三方购买的肥料。农源购买事项及农源销售事项交易额分别约为3.166亿港元及280万港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.